Inhance
Device Ortho-Shoulder
PDI 10603295539377
General payments
$6,351,443
Research payments
$242,184
Through program year 2025, $6,351,443 in general payments and $242,184 in research payments were reported against Inhance (Ortho-Shoulder).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $3,433,100 | 1,226 |
| 2025 | Research | $238,672 | 59 |
| 2024 | General | $1,653,354 | 851 |
| 2024 | Research | $3,512 | 1 |
| 2023 | General | $1,055,027 | 806 |
| 2022 | General | $185,188 | 152 |
| 2021 | General | $24,774 | 52 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,087 general · 60 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.